Femasys inc. announces financial results for the year ended december 31, 2021

-- company builds out management team and continues to implement its clinical programs to advance much-needed technologies for women's health -- atlanta, march 24, 2022 (globe newswire) -- femasys inc. (nasdaq: femy), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced financial results for the year ended december 31, 2021.
FEMY Ratings Summary
FEMY Quant Ranking